New shot tested to regrow hair in autoimmune baldness
Disease control
Recruiting now
This is a first-in-human study to check the safety of an experimental drug called HCW9302 in people with alopecia areata, an autoimmune condition that causes hair loss. About 30 adults will receive injections, starting with low doses to monitor for side effects. The main goal is …
Phase: PHASE1 • Sponsor: HCW Biologics • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC